Inspection Record

Isologic Innovative Radiopharmaceuticals Ltd. — Health Canada Inspection Findings

Health CanadaInspected 2021-08-03 7 findingsOther quality systemEquipment and facilityContamination controlLaboratory and QC controlsDeviation, CAPA, and investigationComputer system validation

View the regulator's official source The source document is always the basis for judgement.

Findings

1Other quality system

The evidence required to demonstrate compliance with finished product specifications was inadequate.

2Equipment and facility

The maintenance of records was inadequate.

3Contamination control

The sanitation programs were not adequately designed to identify and/or reduce the risks of contamination.

4Laboratory and QC controls

The creation, maintenance, processing, and/or review of laboratory data was inadequate.

5Deviation, CAPA, and investigation

Investigations into deviations, reports, and/or follow-up actions were inadequate. The investigation, handling, and/or reporting of test results that were out-of-specification was inadequate.

6Other quality system

The control of quarantine areas was inadequate.

7Computer system validation

The calibration, inspection, and/or qualification of the equipment, including computerized systems, was inadequate.

About this record

Extracted automatically from the document of the Health Canada inspection on 2021-08-03. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Other records for this company

Isologic Innovative Radiopharmaceuticals Ltd. company profile — full history Health Canada documents, 2021 Go to Findings search